Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients

Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients Publisher

Summary: High calprotectin levels might predict severity in STEMI patients, hinting at its potential as a cardiac marker. Could it transform patient management? #Cardiology #STEMI

Heybar H ; Ramezani B ; Assareh AR ; Kardooni A ; Azizidoost S

Source: Advanced Biomedical Research Published:2024

Abstract

Background: Calprotectin is recognized as a promising prognostic as well as a diagnostic marker of cardiac disorders. In the present study, we aimed to survey the efficiency of serum calprotectin levels in anticipating the severity of coronary artery disease (CAD) along with in-hospital major adverse cardiovascular events (MACE) in patients with ST-segment elevation (STEMI) underlying primary percutaneous coronary intervention (PCI). Materials and Methods: A total of 97 patients with STEMI participated and were evaluated for in-hospital MACE for possible correlation with serum calprotectin. Results: Increased levels of serum calprotectin showed positive and negative correlation with severity of coronary arteries and left ventricular ejection fraction (LVEF) of STEMI patients, respectively. Regarding in-hospital MACE, only arrhythmia showed a significant relationship in patients with high calprotectin levels. Conclusion: High calprotectin levels may be a prognostic marker for occluded artery and LVEF in STEMI patients. © 2025 Elsevier B.V., All rights reserved.

Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients

Style	Citing Format
MLA	Heybar H, et al.. "Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients." Advanced Biomedical Research, vol. 13, no. 1, 2024, pp. -.
APA	Heybar H, Ramezani B, Assareh AR, Kardooni A, Azizidoost S (2024). Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients. Advanced Biomedical Research, 13(1), -.
Chicago	Heybar H, Ramezani B, Assareh AR, Kardooni A, Azizidoost S. "Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients." Advanced Biomedical Research 13, no. 1 (2024): -.
Harvard	Heybar H et al. (2024) 'Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients', Advanced Biomedical Research, 13(1), pp. -.
Vancouver	Heybar H, Ramezani B, Assareh AR, Kardooni A, Azizidoost S. Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients. Advanced Biomedical Research. 2024;13(1):-.
BibTex	@article{ author = {Heybar H and Ramezani B and Assareh AR and Kardooni A and Azizidoost S}, title = {Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients}, journal = {Advanced Biomedical Research}, volume = {13}, number = {1}, pages = {-}, year = {2024} }
RIS	TY - JOUR AU - Heybar H AU - Ramezani B AU - Assareh AR AU - Kardooni A AU - Azizidoost S TI - Calprotectin Correlates With Reduced Level of Lvef and Occurrence of Cardiac Arrhythmia in Stemi Patients JO - Advanced Biomedical Research VL - 13 IS - 1 SP - EP - PY - 2024 ER -

Science Communicator Platform

Authors

Abstract